Research & Development service

This service, which brings together high-level engineers (1 IR and 2 IE) with complementary expertise, was created in early 2024 to develop new preclinical models and experimental protocols to meet the needs of the projects of the various IGF teams. The technological axes already in place or in the process of being implemented include :

The development of new functional tests in preclinical models
Development of stem cell and organoid models
The generation of new cellular and viral models by genome editing.

The engineers in this service are responsible for assisting the teams in the development of these tools and approaches, and for training team members in these new technologies.
The activities of the R&D service are monitored by a Steering Committee made up of the scientific heads of the engineers in the service and representatives of management.

Manager
Philippe MARIN

IGF staff involved

Researchers